However, based on our results that demonstrate that pathological B cell–intrinsic RANK signaling can promote immunopathology, investigating additional effects of anti-RANKL treatment on B lymphocytes is important in RA models and in human autoreactive B cell responses. Here, TNFRSF11A is linked to rheumatoid arthritis.